Prometheus Biosciences, Inc.
RXDXDelisted Jun 16, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001718852
Prometheus Biosciences, Inc. was delisted on Jun 16, 2023; its insiders filed their last Form 4 on Jun 16, 2023; 220 institutions reported holding it in 13F filings for Q1 2023, worth $4.35B in total; no superinvestor held it.
Holders of 5% or more of RXDX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Prometheus Biosciences, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Prometheus Biosciences, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
21 Schedule 13D and 13G filings on Prometheus Biosciences, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Mar 8, 2023 | Cedars Sinai Intellectual Property Co | 13G/AOld format | – | – | – | SEC |
| Feb 17, 2023 | Cedars Sinai Intellectual Property Co | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Eventide Asset Management, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Perceptive Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Cormorant Asset Management, LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | RTW Investments, LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Point72 Asset Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 3, 202312:09 PM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Jun 7, 2022 | Cormorant Asset Management, LP | 13GOld format | – | – | – | SEC |
| May 9, 20223:23 PM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Feb 14, 2022 | Eventide Asset Management, LLC | 13GOld format | – | New | – | SEC |
| Feb 14, 2022 | Perceptive Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Nestle Health Science US Holdings, Inc. | 13GOld format | – | New | – | SEC |
| Feb 14, 2022 | Cormorant Asset Management, LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Point72 Asset Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Cedars Sinai Intellectual Property Co | 13GOld format | – | New | – | SEC |
| Feb 4, 20224:12 PM ET | BlackRock Inc. | 13GOld format | – | New | – | SEC |
| Mar 26, 2021 | Cormorant Asset Management, LP | 13GOld format | – | New | – | SEC |
| Mar 22, 2021 | Point72 Asset Management, L.P. | 13GOld format | – | New | – | SEC |
| Mar 18, 2021 | Perceptive Advisors LLC | 13GOld format | – | New | – | SEC |
| Mar 17, 2021 | RTW Investments, LP | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
1 notice from officers, directors and other affiliates planning to sell Prometheus Biosciences, Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Mar 8, 20235:00 PM ET | Cedars Sinai Intellectual Property Company10% stockholder | 865.0K | $104.4M | Mar 8, 2023 | Jefferies, LLC | SEC |